Active-ingredient Dossier
Anastrozole
Active-ingredient Dossier for Anastrozole (aromatase inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: APO-ANASTROZOLE
- Brand: ANASTROZOLE
- Brand: ANASTROZOLE-GH
- Brand: ARIANNA
- Brand: ARIMIDEX
- Brand: ANASTROZOLE
- Therapeutic area: Oncology
What is
Anastrozole Anastrozole is an aromatase inhibitor.
Australian brands containing
Anastrozole — APO-ANASTROZOLE — ARIMIDEX — ANASTROZOLE — ANASTROZOLE-GH — ANASTROZOLE-WGR — ARIANNA
Therapeutic areas
Anastrozole is registered in oncology, with 12 brands containing this ingredient on the ARTG.
Sponsor landscape
Anastrozole is marketed by eleven sponsors: Arrotex Pharmaceuticals, Sandoz, Accord Healthcare, Strides Pharma Science, Southern Cross Pharma, and Generic Health.
PBS and regulatory activity
One brand containing anastrozole has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 March 2022, with two brands having PBAC outcomes recorded and no AusPARs on record.